Mahmoud M. Mohy El‐Din

579 total citations
29 papers, 532 citations indexed

About

Mahmoud M. Mohy El‐Din is a scholar working on Molecular Biology, Physiology and Physiology. According to data from OpenAlex, Mahmoud M. Mohy El‐Din has authored 29 papers receiving a total of 532 indexed citations (citations by other indexed papers that have themselves been cited), including 11 papers in Molecular Biology, 10 papers in Physiology and 7 papers in Physiology. Recurrent topics in Mahmoud M. Mohy El‐Din's work include Nitric Oxide and Endothelin Effects (7 papers), Adenosine and Purinergic Signaling (7 papers) and Neuroscience and Neuropharmacology Research (5 papers). Mahmoud M. Mohy El‐Din is often cited by papers focused on Nitric Oxide and Endothelin Effects (7 papers), Adenosine and Purinergic Signaling (7 papers) and Neuroscience and Neuropharmacology Research (5 papers). Mahmoud M. Mohy El‐Din collaborates with scholars based in Egypt, United States and Lebanon. Mahmoud M. Mohy El‐Din's co-authors include Mahmoud M. El‐Mas, Amal G. Omar, Fouad M. Sharabi, Kafait U. Malik, Mai M. Helmy, Elham A. Afify, Ahmed El‐Mallah, Maged W. Helmy, Amira Senbel and Sahar M. El‐Gowilly and has published in prestigious journals such as Brain Research, The FASEB Journal and Neuroscience.

In The Last Decade

Mahmoud M. Mohy El‐Din

29 papers receiving 528 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Mahmoud M. Mohy El‐Din Egypt 13 153 125 103 79 68 29 532
Neide Hyppolito Jurkiewicz Brazil 14 289 1.9× 90 0.7× 159 1.5× 101 1.3× 43 0.6× 58 683
Lei‐Ming Ren China 15 237 1.5× 108 0.9× 159 1.5× 26 0.3× 89 1.3× 74 605
Eylem Taşkın Türkiye 17 165 1.1× 154 1.2× 87 0.8× 82 1.0× 16 0.2× 35 613
Glenn Harrison Australia 16 156 1.0× 160 1.3× 124 1.2× 42 0.5× 100 1.5× 32 658
Amal G. Omar Egypt 13 93 0.6× 122 1.0× 94 0.9× 80 1.0× 62 0.9× 19 420
Elham A. Afify Egypt 12 113 0.7× 88 0.7× 132 1.3× 107 1.4× 37 0.5× 23 489
Gabriel Tavares do Vale Brazil 16 155 1.0× 131 1.0× 122 1.2× 85 1.1× 8 0.1× 41 716
Sahar M. El‐Gowilly Egypt 16 175 1.1× 182 1.5× 105 1.0× 43 0.5× 50 0.7× 52 594

Countries citing papers authored by Mahmoud M. Mohy El‐Din

Since Specialization
Citations

This map shows the geographic impact of Mahmoud M. Mohy El‐Din's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mahmoud M. Mohy El‐Din with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mahmoud M. Mohy El‐Din more than expected).

Fields of papers citing papers by Mahmoud M. Mohy El‐Din

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Mahmoud M. Mohy El‐Din. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mahmoud M. Mohy El‐Din. The network helps show where Mahmoud M. Mohy El‐Din may publish in the future.

Co-authorship network of co-authors of Mahmoud M. Mohy El‐Din

This figure shows the co-authorship network connecting the top 25 collaborators of Mahmoud M. Mohy El‐Din. A scholar is included among the top collaborators of Mahmoud M. Mohy El‐Din based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Mahmoud M. Mohy El‐Din. Mahmoud M. Mohy El‐Din is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
El-Ganainy, Samar O., et al.. (2019). A novel investigation of statins myotoxic mechanism: effect of atorvastatin on respiratory muscles in hypoxic environment. Toxicology Letters. 305. 58–64. 2 indexed citations
2.
El-Ganainy, Samar O., et al.. (2016). Elucidation of the mechanism of atorvastatin-induced myopathy in a rat model. Toxicology. 359-360. 29–38. 21 indexed citations
3.
El-Ganainy, Samar O., et al.. (2016). Rosuvastatin safety: An experimental study of myotoxic effects and mitochondrial alterations in rats. Toxicology Letters. 265. 23–29. 9 indexed citations
4.
5.
6.
Helmy, Mai M., et al.. (2014). Selective ETA receptor blockade protects against cisplatin-induced acute renal failure in male rats. European Journal of Pharmacology. 730. 133–139. 28 indexed citations
7.
Nasser, Suzanne A., et al.. (2014). Blockade of endothelin ETA, but not thromboxane, receptors offsets the cyclosporine-evoked hypertension and interrelated baroreflex and vascular dysfunctions. European Journal of Pharmacology. 727. 52–59. 24 indexed citations
8.
El‐Mas, Mahmoud M., Mahmoud M. Mohy El‐Din, Mai M. Helmy, & Amal G. Omar. (2012). Redox imbalances incite the hypertensive, baroreflex, and autonomic effects of cyclosporine in rats. European Journal of Pharmacology. 694(1-3). 82–88. 26 indexed citations
9.
Harraz, Osama F., et al.. (2012). Adenosinergic modulation of the imidazoline I1-receptor-dependent hypotensive effect of ethanol in acute renal failure. Food and Chemical Toxicology. 50(8). 2622–2628. 6 indexed citations
10.
El‐Mas, Mahmoud M., Amal G. Omar, Mai M. Helmy, & Mahmoud M. Mohy El‐Din. (2011). Crosstalk between central pathways of nitric oxide and carbon monoxide in the hypertensive action of cyclosporine. Neuropharmacology. 62(4). 1890–1896. 28 indexed citations
11.
El‐Din, Mahmoud M. Mohy, et al.. (2010). A Novel COX‐2 Inhibitor Pyrazole Derivative Proven Effective as an Anti‐Inflammatory and Analgesic Drug. Basic & Clinical Pharmacology & Toxicology. 108(4). 263–273. 53 indexed citations
12.
13.
El‐Mas, Mahmoud M., Amal G. Omar, Mai M. Helmy, & Mahmoud M. Mohy El‐Din. (2008). Interruption of central neuronal pathway of imidazoline I1 receptor mediates the hypertensive effect of cyclosporine in rats. Brain Research. 1248. 96–106. 12 indexed citations
14.
El‐Mas, Mahmoud M., Fouad M. Sharabi, Sahar M. El‐Gowilly, & Mahmoud M. Mohy El‐Din. (2006). Inhibition of nitric oxide-guanylate cyclase-dependent and -independent signaling contributes to impairment of β-adrenergic vasorelaxations by cyclosporine. Biochemical Pharmacology. 73(3). 359–367. 6 indexed citations
15.
El‐Din, Mahmoud M. Mohy, Amira Senbel, Tahia T. Daabees, & Fouad M. Sharabi. (2006). Peripheral Modulation of Dopaminergic Receptors Affects Erectile Responses in Rats. Basic & Clinical Pharmacology & Toxicology. 100(4). 225–232. 8 indexed citations
16.
El‐Mas, Mahmoud M., Mahmoud M. Mohy El‐Din, Sahar M. El‐Gowilly, & Fouad M. Sharabi. (2004). Regional and Endothelial Differences in Cyclosporine Attenuation of Adenosine Receptor-Mediated Vasorelaxations. Journal of Cardiovascular Pharmacology. 43(4). 562–573. 28 indexed citations
17.
El‐Mas, Mahmoud M., Elham A. Afify, Mahmoud M. Mohy El‐Din, Amal G. Omar, & Fouad M. Sharabi. (2001). Testosterone Facilitates the Baroreceptor Control of Reflex Bradycardia: Role of Cardiac Sympathetic and Parasympathetic Components. Journal of Cardiovascular Pharmacology. 38(5). 754–763. 81 indexed citations
18.
El‐Din, Mahmoud M. Mohy & Kafait U. Malik. (1988). Differential effect of ω‐conotoxin on release of the adrenergic transmitter and the vasoconstrictor response to noradrenaline in the rat isolated kidney. British Journal of Pharmacology. 94(2). 355–362. 53 indexed citations
19.
El‐Din, Mahmoud M. Mohy & Kafait U. Malik. (1988). Mechanism of norepinephrine release elicited by Na+-K+ adenosine triphosphatase inhibition in the isolated rat kidney: involvement of voltage-dependent Ca++ channels.. Journal of Pharmacology and Experimental Therapeutics. 245(2). 436–443. 2 indexed citations
20.
El‐Din, Mahmoud M. Mohy & Kafait U. Malik. (1987). Mechanism of norepinephrine release elicited by renal nerve stimulation, veratridine and potassium chloride in the isolated rat kidney.. Journal of Pharmacology and Experimental Therapeutics. 243(1). 76–85. 8 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Neide Hyppolito Jurkiewicz Breakdown of academic impact, for papers by Lei‐Ming Ren Breakdown of academic impact, for papers by Eylem Taşkın Breakdown of academic impact, for papers by Glenn Harrison Breakdown of academic impact, for papers by Amal G. Omar Breakdown of academic impact, for papers by Elham A. Afify Breakdown of academic impact, for papers by Gabriel Tavares do Vale Breakdown of academic impact, for papers by Sahar M. El‐Gowilly
Rankless by CCL
2026